Thomas Englese
Förmögenhet: 9 785 $ per 2026-08-31
Förmögenhet: 9 785 $ per 2026-08-31
Mr. Thomas J.
Englese is a Chief Commercial Officer at Tonix Pharmaceuticals Holding Corp.
He is on the Board of Directors at Therakos (UK) Ltd. Mr. Englese was previously employed as a Chief Commercial Officer by Elutia, Inc., a General Manager-North America Hospital Therapies by Mallinckrodt Plc, a Vice President-Customer Operations by Ikaria, Inc., a Senior Director-Business Operations by Baxter International, Inc., and a Chief Commercial Officer by Tris Pharma, Inc. He received his undergraduate degree from Villanova University and an MBA from The Pennsylvania State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-04 | 694 ( 0,01 % ) | 9 785 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Företagsledare/Principal | 2024-09-10 |
Therakos (UK) Ltd.
Therakos (UK) Ltd. Medical/Nursing ServicesHealth Services Develops immune cell therapies delivered through extracorporeal photopheresis | Direktör/Styrelseledamot | 2015-10-30 |
| Företag | Position | Slut |
|---|---|---|
| MALLINCKRODT PLC | Företagsledare/Principal | 2019-07-01 |
| IKARIA, INC. | Företagsledare/Principal | 2015-03-01 |
| BAXTER INTERNATIONAL INC. | Företagsledare/Principal | 2008-01-01 |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Företagsledare/Principal | - |
| ELUTIA INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Ikaria, Inc.
Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
Keenova Therapeutics Plc
Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics & diagnostics products to treat and prevent human disease and alleviate suffering | Health Technology |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Therakos (UK) Ltd.
Therakos (UK) Ltd. Medical/Nursing ServicesHealth Services Develops immune cell therapies delivered through extracorporeal photopheresis | Health Services |
Elutia, Inc.
Elutia, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops customized tissue products | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån